Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?

How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?

(2023) Michael Drummond et al.   BMC HEALTH SERVICES RESEARCH

Using World Cafés to engage an Australian culturally and linguistically diverse community around human papillomavirus vaccination

(2023) Kathleen Prokopovich et al.   HEALTH EXPECTATIONS

Living health technology assessments: how close to living reality?

(2023) Grammati Sarri et al.   BMJ Evidence-Based Medicine

A Conceptual Framework for Life-Cycle Health Technology Assessment

(2022) Erin Kirwin et al.   VALUE IN HEALTH

Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study

(2022) Idaira Rodriguez-Santana et al.   Orphanet Journal of Rare Diseases

Clinical gene technology in Australia: building on solid foundations

(2022) Gabrielle O'Sullivan et al.   MEDICAL JOURNAL OF AUSTRALIA

HTA decision-making for drugs for rare diseases: comparison of processes across countries

(2022) Tania Stafinski et al.   Orphanet Journal of Rare Diseases

Older Adults’ Perspectives of Smart Technologies to Support Aging at Home: Insights from Five World Café Forums

(2022) Jackie Street et al.   International Journal of Environmental Research and Public Health

Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia

(2022) Heather G. Mack et al.   GENE THERAPY

Moving beyond the Court of Public Opinion: A Citizens’ Jury Exploring the Public’s Values around Funding Decisions for Ultra-Orphan Drugs

(2022) Tania Stafinski et al.   International Journal of Environmental Research and Public Health

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision

(2021) Simone A. Huygens et al.   PHARMACOECONOMICS

Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models

(2021) Hossein Haji Ali Afzali et al.   VALUE IN HEALTH

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

(2021) Nirali N. Shah et al.   JOURNAL OF CLINICAL ONCOLOGY

PBI35 HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL & GENE THERAPIES: THE ROAD TO REIMBURSEMENT

(2020) B.K. Vu et al.   VALUE IN HEALTH

An Ethical Analysis of Coverage with Evidence Development

(2019) Drew Carter et al.   VALUE IN HEALTH

Structuring a conceptual model for cost-effectiveness analysis of frailty interventions

(2019) Hossein Haji Ali Afzali et al.   PLoS One

Model Structuring for Economic Evaluations of New Health Technologies

(2018) Hossein Haji Ali Afzali et al.   PHARMACOECONOMICS

The Use of MCDA in HTA: Great Potential, but More Effort Needed

(2018) Kevin D. Marsh et al.   VALUE IN HEALTH

CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS IN AUSTRALIA

(2017) Maxine F. Robinson et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users

(2015) P. Vemer et al.   PHARMACOECONOMICS

The use of citizens' juries in health policy decision-making: A systematic review

(2014) Jackie Street et al.   SOCIAL SCIENCE & MEDICINE

Improving the Accuracy and Comparability of Model-Based Economic Evaluations of Health Technologies for Reimbursement Decisions

(2012) Hossein Haji Ali Afzali et al.   MEDICAL DECISION MAKING

Scoping studies: advancing the methodology

(2010) Danielle Levac et al.   Implementation Science